List B M, Klatt P, Werner E R, Schmidt K, Mayer B
Institut für Pharmakologie und Toxikologie, Karl-Franzens-UniversitätGraz, Austria.
Biochem J. 1996 Apr 1;315 ( Pt 1)(Pt 1):57-63. doi: 10.1042/bj3150057.
Nitric oxide synthase (NOS) catalyses the conversion of L-arginine into L-citrulline and nitric oxide. Recently we have developed a method for expression of recombinant rat brain NOS in baculovirus-infected Sf9 cells and purification of the enzymically active enzyme [Harteneck, Klatt, Schmidt and Mayer (1994) Biochem J. 304, 683-686]. To study how biosynthetic manipulation of the NOS cofactors haem, FAD/FMN, and tetrahydrobiopterin (H4biopterin) affects the properties of the isolated enzyme, Sf9 cells were infected in the absence and presence of haemin chloride (4 microg/ml), riboflavin (0.1.mM), and the inhibitor of H4biopterin biosynthesis 2,4-diamino-6-hydroxypyrimidine (10 mM). In the absence of haemin, NOS was expressed to a very high level but remained predominantly insoluble. Purification of the soluble fraction of the expressed protein showed that it had poor activity (0.35 micromol of citrulline x mg(-1) x min(-1)) and was haem-deficient (0.37 equiv. per monomer). Supplementing the culture medium with haemin resulted in pronounced solubilization of the expressed enzyme, which had a specific activity of approximately 1 micromol of citrulline x mg(-1) x min(-1) and contained 0.95 equiv. of haem per monomer under these conditions. Unexpectedly, the amount of H(4) biopterin endogenously present in the different NOS preparations positively correlated with the amount of enzyme-bound haem (y = 0.066+0.430x; r = 0.998). Radioligand binding experiments demonstrated that haem-deficient enzyme preparations containing 30-40% of the holoenzyme bound only approximately 40% of H4biopterin as compared with haem-saturated controls. These results suggest that the prosthetic haem group is essentially involved in the correct folding of NOS that is a requisite for solubilization of the protein and tight binding of H4biopterin.
一氧化氮合酶(NOS)催化L - 精氨酸转化为L - 瓜氨酸和一氧化氮。最近我们开发了一种在杆状病毒感染的Sf9细胞中表达重组大鼠脑NOS并纯化具有酶活性的该酶的方法[哈滕内克、克拉特、施密特和迈尔(1994年)《生物化学杂志》。304卷,683 - 686页]。为了研究NOS辅因子血红素、FAD/FMN和四氢生物蝶呤(H4生物蝶呤)的生物合成操作如何影响分离出的酶的性质,在有无氯化血红素(4微克/毫升)、核黄素(0.1毫摩尔)和H4生物蝶呤生物合成抑制剂2,4 - 二氨基 - 6 - 羟基嘧啶(10毫摩尔)的情况下感染Sf9细胞。在没有血红素的情况下,NOS表达水平非常高,但主要仍不溶。对表达蛋白的可溶部分进行纯化显示其活性较差(0.35微摩尔瓜氨酸×毫克⁻¹×分钟⁻¹)且血红素缺乏(每个单体0.37当量)。在培养基中添加血红素导致表达的酶明显溶解,在这些条件下其比活性约为1微摩尔瓜氨酸×毫克⁻¹×分钟⁻¹,每个单体含有0.95当量的血红素。出乎意料的是,不同NOS制剂中内源性存在的H4生物蝶呤的量与酶结合的血红素的量呈正相关(y = 0.066 + 0.430x;r = 0.998)。放射性配体结合实验表明,与血红素饱和的对照相比,含有30 - 40%全酶的血红素缺乏的酶制剂仅结合约40%的H4生物蝶呤。这些结果表明,辅基血红素基团基本上参与了NOS的正确折叠,而这是蛋白质溶解和H4生物蝶呤紧密结合所必需的。